ASSESSMENT OF THE PREVALENCE OF SEXUAL DYSFUNCTION AND ASSOCIATED FACTORS AMONG DIABETIC MEN ATTENDING FOLLOW UP CLINIC AT HAWASSA UNIVERSITY COMPREHENSIVE SPECIALIZED HOSPITAL, SIDAMA REGIONAL STATE, ETHIOPIA, 2023/24

Authors: Tadele Kegnu*, Akberet Semere, Ashagrachew Haile & Yegzeru Belete

ABSTRACT

Background: Sexual dysfunction is a prevalent issue among adult males, leading to withdrawal from sexual relationships and various psychosocial challenges such as low self-esteem, depression, and anxiety. It can also result in decreased work productivity and negatively affect the quality of life for both the affected men and their female partners. Furthermore, sexual dysfunction can have significant economic repercussions for employers, as men experiencing this condition tend to have higher rates of absenteeism, presenteeism (working while impaired), and overall productivity loss compared to their counterparts without sexual dysfunction.

Objectives: This study aimed to evaluate the prevalence of sexual dysfunction and its associated factors in men with diabetes mellitus attending the follow-up clinic at Hawassa University Comprehensive Specialized Hospital.

Methodology: A cross-sectional study was conducted at Hawassa University Comprehensive Specialized Hospital, targeting a sample size of 204 men. Ultimately, 200 participants were interviewed, resulting in a response rate of 98%. The data were analysed using SPSS version 25, with results presented in frequency tables and cross-tabulations of selected variables. A binary logistic regression model was employed to identify factors linked to sexual dysfunction.

Results: The overall prevalence of sexual dysfunction among men with diabetes mellitus was found to be 71.5%. Significant associations were identified between sexual dysfunction and factors such as higher body mass index, being single, experiencing anxiety or depression, and physical inactivity.

Conclusion: Over two-thirds of men with diabetes report sexual dysfunction, a higher prevalence than in other studies. This finding underscores the necessity of incorporating the assessment and management of sexual dysfunction into standard medical care during diabetes follow-up appointments. Modifiable factors like depression, anxiety, physical inactivity, and high BMI should also be addressed.

REFERENCES

  1. Sun et al., “IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.,” Diabetes Res. Clin. Pract., vol. 183, p. 109119, Jan. 2022, doi: 10.1016/j.diabres.2021.109119.
  2. Ogurtsova et al., “IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021.,” Diabetes Res. Clin. Pract., vol. 183, p. 109118, Jan. 2022, doi: 10.1016/j.diabres.2021.109118.
  3. H. Cho et al., “IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.,” Diabetes Res. Clin. Pract., vol. 138, pp. 271–281, Apr. 2018, doi: 10.1016/j.diabres.2018.02.023.
  4. Mineral Commodities Ltd, “Annual Report,” Miner. Commod. Ltd ACN 008 478 653, no. April, p. 134, 2022, [Online]. Available: www.moh.gov.my
  5. Animaw and Y. Seyoum, “Increasing prevalence of diabetes mellitus in a developing country and its related factors.,” PLoS One, vol. 12, no. 11, p. e0187670, 2017, doi: 10.1371/journal.pone.0187670.
  6. G. Kopelman, “Obesity as a medical problem.,” Nature, vol. 404, no. 6778, pp. 635–643, Apr. 2000, doi: 10.1038/35007508.
  7. S. Go et al., “heart disease and stroke statistics–2013 update: a report from the American Heart Association.,” Circulation, vol. 127, no. 1, pp. e6–e245, Jan. 2013, doi: 10.1161/CIR.0b013e31828124ad.
  8. Kozak, International Diabetes Federation (IDF) highlights growing global impact of diabetes in 5th edition of the Diabetes Atlas. 2012. [Online]. Available: https://diabetesatlas.org/atlas/tenth-edition/%0Ahttps://diabetesatlas.org/data/en/world/
  9. Campos, “Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae.,” Postgrad. Med., vol. 124, no. 6, pp. 90–97, Nov. 2012, doi: 10.3810/pgm.2012.11.2615.
  10. Rahman, T. Rahman, A. A.-S. Ismail, and A. R. A. Rashid, “Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.,” Diabetes. Obes. Metab., vol. 9, no. 6, pp. 767–780, Nov. 2007, doi: 10.1111/j.1463-1326.2006.00655. x.
  11. S. Fox et al., “Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.,” Circulation, vol. 115, no. 12, pp. 1544–1550, Mar. 2007, doi: 10.1161/CIRCULATIONAHA.106.658948.
  12. R. Preis et al., “Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.,” Circulation, vol. 120, no. 3, pp. 212–220, Jul. 2009, doi: 10.1161/CIRCULATIONAHA.108.846519.
  13. M. Nathan et al., “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.,” N. Engl. J. Med., vol. 329, no. 14, pp. 977–986, Sep. 1993, doi: 10.1056/NEJM199309303291401.
  14. M. Stratton et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.,” BMJ, vol. 321, no. 7258, pp. 405–412, Aug. 2000, doi: 10.1136/bmj.321.7258.405.
  15. A. Feldman, I. Goldstein, D. G. Hatzichristou, R. J. Krane, and J. B. McKinlay, “Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.,” J. Urol., vol. 151, no. 1, pp. 54–61, Jan. 1994, doi: 10.1016/s0022-5347(17)34871-1.
  16. -C. Lu, B.-P. Jiann, C.-C. Sun, H.-C. Lam, C.-H. Chu, and J.-K. Lee, “Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes.,” J. Sex. Med., vol. 6, no. 6, pp. 1719–1728, Jun. 2009, doi: 10.1111/j.1743-6109.2009.01219.x.
  17. Giugliano, M. Maiorino, G. Bellastella, M. Gicchino, D. Giugliano, and K. Esposito, “Determinants of erectile dysfunction in type 2 diabetes.,” Int. J. Impot. Res., vol. 22, no. 3, pp. 204–209, 2010, doi: 10.1038/ijir.2010.1.
  18. Enzlin et al., “Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort.,” Diabetes Care, vol. 32, no. 5, pp. 780–785, May 2009, doi: 10.2337/dc08-1164.
  19. M. Abu Ali, R. M. Al Hajeri, Y. S. Khader, N. S. Shegem, and K. M. Ajlouni, “Sexual dysfunction in Jordanian diabetic women.,” Diabetes Care, vol. 31, no. 8, pp. 1580–1581, Aug. 2008, doi: 10.2337/dc08-0081.
  20. Salonia et al., “Sexual function and endocrine profile in fertile women with type 1 diabetes.,” Diabetes Care, vol. 29, no. 2, pp. 312–316, Feb. 2006, doi: 10.2337/diacare.29.02.06.dc05-1067.
  21. Selvin, A. L. Burnett, and E. A. Platz, “Prevalence and risk factors for erectile dysfunction in the US.,” Am. J. Med., vol. 120, no. 2, pp. 151–157, Feb. 2007, doi: 10.1016/j.amjmed.2006.06.010.
  22. A. Giuliano, A. Leriche, E. O. Jaudinot, and A. S. de Gendre, “Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both.,” Urology, vol. 64, no. 6, pp. 1196–1201, Dec. 2004, doi: 10.1016/j.urology.2004.08.059.
  23. O. Laumann et al., “Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors.,” Int. J. Impot. Res., vol. 17, no. 1, pp. 39–57, 2005, doi: 10.1038/sj.ijir.3901250.
  24. M. Lee, J. Nazroo, D. B. O’Connor, M. Blake, and N. Pendleton, “Sexual Health and Well-being Among Older Men and Women in England: Findings from the English Longitudinal Study of Ageing.,” Arch. Sex. Behav., vol. 45, no. 1, pp. 133–144, Jan. 2016, doi: 10.1007/s10508-014-0465-1.
  25. Lotti and M. Maggi, “Sexual dysfunction and male infertility.,” Nat. Rev. Urol., vol. 15, no. 5, pp. 287–307, May 2018, doi: 10.1038/nrurol.2018.20.
  26. H. Blanker et al., “Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity.,” Urology, vol. 57, no. 4, pp. 763–768, Apr. 2001, doi: 10.1016/s0090-4295(00)01091-8.
  27. Sharifi, M. Asghari, Y. Jaberi, O. Salehi, and F. Mirzamohammadi, “Independent Predictors of Erectile Dysfunction in Type 2 Diabetes Mellitus: Is It True What They Say about Risk Factors?” ISRN Endocrinol., vol. 2012, p. 502353, 2012, doi: 10.5402/2012/502353.
  28. Fedele et al., “Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.,” Diabetes Care, vol. 21, no. 11, pp. 1973–1977, Nov. 1998, doi: 10.2337/diacare.21.11.1973.
  29. Minami et al., “Physical activity and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study.,” J. Diabetes Investig., vol. 9, no. 1, pp. 193–198, Jan. 2018, doi: 10.1111/jdi.12660.
  30. H. Cho et al., “Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus.,” Diabet. Med., vol. 23, no. 2, pp. 198–203, Feb. 2006, doi: 10.1111/j.1464-5491.2005.01789.x.
  31. Dan, K. Chakraborty, M. Mondal, R. Neogi, S. Chatterjee, and M. Makhal, “Erectile dysfunction in patients with diabetes mellitus: its magnitude, predictors and their bio-psycho-social interaction: a study from a developing country.,” Asian J. Psychiatr., vol. 7, no. 1, pp. 58–65, Feb. 2014, doi: 10.1016/j.ajp.2013.10.012.
  32. Ekoru et al., “Type 2 diabetes complications and comorbidity in Sub-Saharan Africans,” EClinicalMedicine, vol. 16, pp. 30–41, 2019, doi: https://doi.org/10.1016/j.eclinm.2019.09.001.
  33. S. Shiferaw, T. Y. Akalu, and Y. A. Aynalem, “Prevalence of Erectile Dysfunction in Patients with Diabetes Mellitus and Its Association with Body Mass Index and Glycated Hemoglobin in Africa: A Systematic Review and Meta-Analysis.,” Int. J. Endocrinol., vol. 2020, p. 5148370, 2020, doi: 10.1155/2020/5148370.
  34. O. Amoo, A. K. Omideyi, T. O. Fadayomi, M. P. Ajayi, G. A. Oni, and A. E. Idowu, “Male reproductive health challenges: appraisal of wives coping strategies,” Reprod. Health, vol. 14, no. 1, p. 90, 2017, doi: 10.1186/s12978-017-0341-2.
  35. Seid, H. Gerensea, S. Tarko, Y. Zenebe, and R. Mezemir, “Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray, northern Ethiopia: a cross-sectional study.,” BMC Endocr. Disord., vol. 17, no. 1, p. 16, Mar. 2017, doi: 10.1186/s12902-017-0167-5.
  36. Walle, K. R. Lebeta, Y. D. Fita, and H. G. Abdissa, “Prevalence of erectile dysfunction and associated factors among diabetic men attending the diabetic clinic at Felege Hiwot Referral Hospital, Bahir Dar, North West Ethiopia, 2016.,” BMC Res. Notes, vol. 11, no. 1, p. 130, Feb. 2018, doi: 10.1186/s13104-018-3211-2.
  37. Getie Mekonnen, H. Y. Yeshita, and A. Bishaw Geremew, “Sexual dysfunction among men with diabetes mellitus attending chronic out-patient department at the three hospitals of Northwest Amhara region, Ethiopia: Prevalence and associated factors.,” PLoS One, vol. 16, no. 8, p. e0256015, 2021, doi: 10.1371/journal.pone.0256015.
  38. Arrellano-Valdez, M. Urrutia-Osorio, C. Arroyo, and E. Soto-Vega, “A comprehensive review of urologic complications in patients with diabetes.,” Springerplus, vol. 3, p. 549, 2014, doi: 10.1186/2193-1801-3-549.
  39. E. Abosetugn and S. S. Yehualashet, “Estimate the burden of sexual dysfunction due to non-communicable diseases in Ethiopia: Systematic review and meta-analysis.,” PLoS One, vol. 16, no. 10, p. e0258938, 2021, doi: 10.1371/journal.pone.0258938.
  40. Keller, E. L. McGarvey, and A. H. Clayton, “Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14).,” J. Sex Marital Ther., vol. 32, no. 1, pp. 43–52, 2006, doi: 10.1080/00926230500232909.
  41. Muturi, “Alcohol consumption and reproductive health risks in rural Central Kenya.,” Sex. Reprod. Healthc. Off. J. Swedish Assoc.  Midwives, vol. 5, no. 2, pp. 41–46, Jun. 2014, doi: 10.1016/j.srhc.2014.01.002.
  42. H. Romeo, A. D. Seftel, Z. T. Madhun, and D. C. Aron, “Sexual function in men with diabetes type 2: association with glycemic control.,” J. Urol., vol. 163, no. 3, pp. 788–791, Mar. 2000.
  43. Hansson, J. Chotai, A. Nordstöm, and O. Bodlund, “Comparison of two self-rating scales to detect depression: HADS and PHQ-9.,” Br. J. Gen. Pract. J. R. Coll.  Gen. Pract., vol. 59, no. 566, pp. e283-8, Sep. 2009, doi: 10.3399/bjgp09X454070.
  44. “Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults–The Evidence Report. National Institutes of Health.,” Obes. Res., vol. 6 Suppl 2, pp. 51S-209S, Sep. 1998.
  45. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale.,” Acta Psychiatr. Scand., vol. 67, no. 6, pp. 361–370, Jun. 1983, doi: 10.1111/j.1600-0447.1983.tb09716.x.
  46. Ziaei-Rad, M. Vahdaninia, and A. Montazeri, “Sexual dysfunctions in patients with diabetes: a study from Iran.,” Reprod. Biol. Endocrinol., vol. 8, p. 50, May 2010, doi: 10.1186/1477-7827-8-50.
  47. Rochester-Eyeguokan and L. Meade, “A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes.,” Diabetes Ther. Res. Treat. Educ. diabetes Relat.  Disord., vol. 8, no. 5, pp. 991–998, Oct. 2017, doi: 10.1007/s13300-017-0313-0.